KUNGSBACKA, Sweden--(BUSINESS WIRE)--Regulatory News: Vitrolife (STO:VITR): * Net sales increased by 10 percent to SEK 96.8 (88.4) million. Adjusted for exchange rate effects, the increase was 13 percent. During the second quarter sales amounted to SEK 47.5 (42.5) million, corresponding to an increase of 12 percent.
